Thymalfasin,

Details:

Introduction to Thymalfasin (Thymus Fasin)

Thymalfasin (Thymus Fasin) is a biological agent, with thymosin as its main component, and it has the function of regulating the immune system. It is mainly used to enhance the immune function and assist in the treatment of viral infection diseases such as chronic hepatitis B.
Historical background and global listing time: Thymalfasin was initially listed in Italy in 1993.
Mechanism of action: Thymofaxin, as an immunomodulator, can regulate the immune function of the body and enhance the body's disease resistance.
Specifically, it works by promoting thymosin production, regulating immune function, and inhibiting viral replication, among other ways. For patients with chronic hepatitis B, thymofaxin can help enhance the body's immune response and promote the recovery of liver function, thereby combating viral infections.
Efficacy and safety

Therapeutic effect: Studies have shown that thymofaxin can significantly improve liver function indicators such as ALT and AST in patients with chronic hepatitis B, and can effectively reduce the degree of liver tissue inflammation.
Long-term follow-up shows that the therapeutic effect remains stable and continuous, reducing the occurrence of complications such as liver cirrhosis.
Safety: Clinical studies have shown that the new thymus method for the treatment of chronic hepatitis B has a relatively high safety and good tolerance.
Common adverse reactions include mild pain and redness and swelling at the injection site, while severe adverse reactions are relatively rare